SCHEMBL23703241

SCHEMBL23703241

CS(=O)(=O)NCc1cccc(-c2cn(C3CC(CN)C3)c3ncnc(N)c23)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IGF1R P08069 15/20 0.57
▸ ABL1 P00519 6/20 0.57
▸ INSR P06213 6/20 0.57
▸ LCK P06239 4/20 0.57
▸ KIT P10721 4/20 0.57
▸ KDR P35968 4/20 0.57
▸ RET P07949 4/20 0.57
▸ LYN P07948 4/20 0.57
▸ SRC P12931 4/20 0.57
▸ PDGFRA P16234 3/20 0.57
▸ FGFR4 P22455 3/20 0.57
▸ FGFR1 P11362 3/20 0.57
▸ FLT1 P17948 3/20 0.57
▸ FLT3 P36888 3/20 0.57
▸ JAK2 O60674 2/20 0.57
▸ FGFR3 P22607 2/20 0.57
▸ ALK Q9UM73 2/20 0.57
▸ CSF1R P07333 2/20 0.57
▸ MET P08581 2/20 0.57
▸ PDGFRB P09619 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30050475 1.00 IGF1R (0.57) IGF1RABL1INSRLCKKIT
SCHEMBL23703240 1.00 IGF1R (0.57) IGF1RABL1INSRLCKKIT
SCHEMBL30051038 0.92 IGF1R (0.68) IGF1RABL1INSRLCKKIT
SCHEMBL30050447 0.92 IGF1R (0.68) IGF1RABL1INSRLCKKIT
SCHEMBL23703163 0.92 IGF1R (0.68) IGF1RABL1INSRLCKKIT
SCHEMBL23703119 0.92 IGF1R (0.68) IGF1RABL1INSRLCKKIT
SCHEMBL23703120 0.92 IGF1R (0.68) IGF1RABL1INSRLCKKIT
SCHEMBL23703090 0.91 IGF1R (0.55) IGF1RABL1INSRLCKKIT
SCHEMBL23703092 0.91 IGF1R (0.55) IGF1RABL1INSRLCKKIT
SCHEMBL30051048 0.91 IGF1R (0.55) IGF1RABL1INSRLCKKIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12195490-B2 STRAD-binding agents and uses thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-01-14 — — US disclosed
CN-115916966-A STRAD binding agents and uses thereof 加利福尼亚大学董事会 2023-04-04 — — CN disclosed
EP-4097223-A1 STRAD-BINDING AGENTS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2022-12-07 — — EP disclosed
WO-2021155004-A1 STRAD-BINDING AGENTS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-08-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12195490-B2 STRAD-binding agents and uses thereof STRAP, STRA6, PLAUR IGF1R 1979/4885ABL1 2110/4885INSR 2388/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback